China
Africa
Publishing solutions for medical publication professionals
Taylor & Francis offers medical communication agencies and publication planners a wide range of publishing solutions. Our portfolio of 370 medical journals and five digital hubs makes us the fourth largest publisher of research funded by the pharmaceutical industry. This includes the Expert Collection, the world’s largest series of review journals in research, development, and clinical medicine.
Get in touch with our expert publishing solutions team to discover how we can help.
Get in touchChoose the right home for your research
Taylor & Francis provides a wide range of journals covering the whole research and development lifecycle. From drug discovery to launch we are here to help you find the right home for your research.
Enter your abstract into our AI-powered journals suggester and find the best journal that matches your abstract. We can help you find the right journal too, guiding you through the process. Get in touch for more information on our open access and accelerated publishing options. E-mail [email protected] to get started.
Industry leaders publishing with us include GlaxoSmithKline, Johnson & Johnson, Merck, Sanofi, Bayer, and more
Increase your impact with publication extenders
Taylor & Francis offers a range of services to meet your needs. We can help simplify and speed up the publishing process and provide an accessible version of your research. Browse the tabs at the top of the page to find a solution that best meets your needs.
Why publish open access?
Open access makes your research freely and permanently available. Anyone, anywhere can read and build upon the research you have published. More and more pharma and healthcare companies are seeing the benefit of open access in meeting their publishing objectives.
Over 375 titles support Industry leaders publishing with us include GlaxoSmithKline, Johnson & Johnson, Merck, China Resources, Sanofi, Bayer, and more
Publishing ethics and research integrity
Taylor & Francis is committed to making sure the work we publish can be trusted. We are a member of the Committee on Publishing Ethics (COPE). Our peer-reviewed journals are published following COPE, ICMJE & GPP-22 guidelines.
How open access can meet your publishing needs
- Increase the discoverability and use of your research
- Increase the number of people able to reach and use your research
- Make an impact beyond your industry reaching policymakers, practitioners, and professionals in your field
- Freely share your work with anyone, anywhere.
- Meet tight publishing timelines with accelerated publishing options
- Expert editorial boards and peer review
Contact us
For more information reach out to our expert team at [email protected]
1Forbes Global 2000: The World’s Largest Public Companies, 2019.
2Pharmaceutical Executive’s Top 50 Companies, 2019.